Reach out to IQVIA to learn more about how to build successful strategies like those seen in the GLP-1s
claims online are for unlicensed, potentially counterfeit products
Individual results vary based on starting weight, dose maintenance, dietary changes, exercise, and program adherence
The American Diabetes Association Standards of Care acknowledge gastrointestinal tolerability as a key consideration when initiating GLP-1 receptor agonist therapy, recommending gradual dose titration to minimize these effects
Our review of the clinical trial pipeline reveals 39 new GLP-1 drugs in development from 34 companies, with only seven among the top 20 pharmaceutical companies
If a pharmacy declines or can't provide one, that's worth knowing before you receive the medication